It is not a cosmetic serum and is not intended for human or veterinary use
To date, tirzepatide, also known as LY3298176, is the only promising dual GIP/GLP-1 receptor agonist ( in vitro ( Though the exact mechanisms underlying GLP-1/GIP synergism are unclear, some hypotheses have suggested that GIP operates directly via the CNS by reducing food intake, increasing the anorexigenic action of GLP-1, or enhancing tolerability to GLP-1R agonists ( Figure 2 )
Eat smaller meals, avoid greasy or very rich foods, stay hydrated, and stop eating at the first sign of fullness
Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications
Quarterly lab panels: A broad baseline followed by targeted follow-up testing, so dosing and protocol track your real biomarkers, not a generic schedule